GROUP ONE TRADING, L.P. - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 46 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$0
-100.0%
294
-85.7%
0.00%–
Q1 2022$4,000
-63.6%
2,059
-19.5%
0.00%–
Q4 2021$11,000
-96.2%
2,559
-84.1%
0.00%–
Q2 2021$290,000–16,093–0.00%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders